Israel · Delayed Price · Currency is ILS · Price in ILA SofWave Medical Statistics
Total Valuation
SofWave Medical has a market cap or net worth of ILS 1.53 billion. The enterprise value is 1.42 billion.
| Market Cap | 1.53B |
| Enterprise Value | 1.42B |
Important Dates
The next estimated earnings date is Wednesday, August 5, 2026.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SofWave Medical has 36.13 million shares outstanding. The number of shares has increased by 19.29% in one year.
| Current Share Class | 36.13M |
| Shares Outstanding | 36.13M |
| Shares Change (YoY) | +19.29% |
| Shares Change (QoQ) | +0.73% |
| Owned by Insiders (%) | 34.47% |
| Owned by Institutions (%) | 31.74% |
| Float | 17.15M |
Valuation Ratios
The trailing PE ratio is 70.37.
| PE Ratio | 70.37 |
| Forward PE | n/a |
| PS Ratio | 5.07 |
| PB Ratio | 13.82 |
| P/TBV Ratio | 13.82 |
| P/FCF Ratio | 36.68 |
| P/OCF Ratio | 34.82 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 39.55, with an EV/FCF ratio of 34.13.
| EV / Earnings | 57.25 |
| EV / Sales | 4.72 |
| EV / EBITDA | 39.55 |
| EV / EBIT | 47.62 |
| EV / FCF | 34.13 |
Financial Position
The company has a current ratio of 2.43, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.43 |
| Quick Ratio | 2.18 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | 0.11 |
| Interest Coverage | 127.72 |
Financial Efficiency
Return on equity (ROE) is 26.52% and return on invested capital (ROIC) is 5,103.11%.
| Return on Equity (ROE) | 26.52% |
| Return on Assets (ROA) | 11.84% |
| Return on Invested Capital (ROIC) | 5,103.11% |
| Return on Capital Employed (ROCE) | 26.17% |
| Weighted Average Cost of Capital (WACC) | 8.18% |
| Revenue Per Employee | 1.99M |
| Profits Per Employee | 164,347 |
| Employee Count | 151 |
| Asset Turnover | 1.91 |
| Inventory Turnover | 4.04 |
Taxes
In the past 12 months, SofWave Medical has paid 1.60 million in taxes.
| Income Tax | 1.60M |
| Effective Tax Rate | 6.05% |
Stock Price Statistics
The stock price has increased by +97.62% in the last 52 weeks. The beta is 0.72, so SofWave Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | +97.62% |
| 50-Day Moving Average | 4,219.44 |
| 200-Day Moving Average | 3,361.39 |
| Relative Strength Index (RSI) | 47.48 |
| Average Volume (20 Days) | 108,106 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SofWave Medical had revenue of ILS 301.12 million and earned 24.82 million in profits. Earnings per share was 0.60.
| Revenue | 301.12M |
| Gross Profit | 225.87M |
| Operating Income | 29.84M |
| Pretax Income | 26.41M |
| Net Income | 24.82M |
| EBITDA | 33.50M |
| EBIT | 29.84M |
| Earnings Per Share (EPS) | 0.60 |
Balance Sheet
The company has 111.00 million in cash and 4.50 million in debt, with a net cash position of 106.50 million or 2.95 per share.
| Cash & Cash Equivalents | 111.00M |
| Total Debt | 4.50M |
| Net Cash | 106.50M |
| Net Cash Per Share | 2.95 |
| Equity (Book Value) | 110.49M |
| Book Value Per Share | 3.06 |
| Working Capital | 97.92M |
Cash Flow
In the last 12 months, operating cash flow was 43.86 million and capital expenditures -2.23 million, giving a free cash flow of 41.64 million.
| Operating Cash Flow | 43.86M |
| Capital Expenditures | -2.23M |
| Depreciation & Amortization | 3.44M |
| Net Borrowing | -2.50M |
| Free Cash Flow | 41.64M |
| FCF Per Share | 1.15 |
Margins
Gross margin is 75.01%, with operating and profit margins of 9.91% and 8.24%.
| Gross Margin | 75.01% |
| Operating Margin | 9.91% |
| Pretax Margin | 8.77% |
| Profit Margin | 8.24% |
| EBITDA Margin | 11.13% |
| EBIT Margin | 9.91% |
| FCF Margin | 13.83% |
Dividends & Yields
SofWave Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.29% |
| Shareholder Yield | -19.29% |
| Earnings Yield | 1.62% |
| FCF Yield | 2.73% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SofWave Medical has an Altman Z-Score of 9.46 and a Piotroski F-Score of 6.
| Altman Z-Score | 9.46 |
| Piotroski F-Score | 6 |